Arexvy

• News

GSK’s Arexvy Is A Vaccine Approved To Protect Older Adults From Respiratory Syncytial Virus (RSV) Disease In Malaysia

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV, a common respiratory… Read More